PL
GSK icon

Parkwood LLC’s GSK GSK Stock Holding History

Parkwood LLC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-38,868
Closed -$2.05M – 475
2017
Q1 		$2.05M Sell
38,868
-12,212
-24% -$620K 0.29% 76
2016
Q4 		$2.46M Buy
51,080
+5,176
+11% +$256K 0.38% 66
2016
Q3 		$2.48M Sell
45,904
-2,182
-5% -$120K 0.37% 68
2016
Q2 		$2.6M Sell
48,086
-5,234
-10% -$276K 0.44% 62
2016
Q1 		$2.7M Buy
53,320
+44,081
+477% +$2.2M 0.46% 48
2015
Q4 		$466K Buy
9,239
+839
+10% +$42.8K 0.07% 265
2015
Q3 		$404K Buy
+8,400
New +$437K 0.07% 220

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Parkwood LLC's GSK Position: Q2 2017 in Review

Parkwood LLC sold out of GSK (GSK) in Q2 2017, closing a stake of 38,868 shares — an estimated $2.05M sold.

Parkwood LLC first reported a position in GSK in Q3 2015 and held it in 7 quarters. The position peaked at $2.7M in Q1 2016. 780 funds tracked by Wall St. Rank hold GSK as of Q2 2017.

  • Parkwood LLC reported no remaining GSK position as of Q2 2017 after selling out during the quarter.
  • Parkwood LLC sold 38,868 GSK shares in Q2 2017, an estimated $2.05M.
  • Parkwood LLC first reported a position in GSK in Q3 2015 and held it in 7 quarters.
  • Parkwood LLC's GSK position peaked at $2.7M in Q1 2016.
  • 780 funds tracked by Wall St. Rank held GSK as of Q2 2017.

Based on Parkwood LLC's 13F filing for Q2 2017, filed 25 Jul 2017.